Skip to main content

Find Clinical Trials

Home
Conditions
Renal Insufficiency

Clinical trial condition

Renal Insufficiency

Explore clinical trials studying Renal Insufficiency. Study availability and eligibility vary by location and protocol.

1,020 public trials 68 recruiting studies

Refine in advanced search Browse all conditions

Renal Insufficiency trial results

Completed

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

NCT01578928

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bloemfontein, Free State, South Africa

View Trial Details

Completed

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

NCT02431481

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Impaired Renal Function, +6 more
Locations: DaVita Clinical Research Minneapolis, Minnesota, United States

Novartis Investigative Site Sofia, Bulgaria

Novartis Investigative Site Prague, Czech Republic, Czechia

Novartis Investigative Site Berlin, Germany

View Trial Details

Completed

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

NCT01613690

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Novartis Investigative Site Moscow, Russia

View Trial Details

Completed

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

NCT02399202

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Novartis Investigative Site Sofia, Bulgaria

Novartis Investigative Site Berlin, Germany

View Trial Details

Completed

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

NCT01558323

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Novartis Investigative Site Orlando, Florida, United States

Novartis Investigative Site Knoxville, Tennessee, United States

View Trial Details

Completed

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

NCT00765830

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
Locations: Clinica de Fracturas y Ortopedia Buenos Aires, Argentina

Hospital Teodoro Alvarez Buenos Aires, Argentina

Instituto de Investigaciones Clinicas de Mar del Plata Buenos Aires, Argentina

Instituto Medico Especializado IME Buenos Aires, Argentina

View all 90 locations

View Trial Details

Completed

Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients

NCT00818571

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +11 more
Locations: Novartis Investigator Site Moscow, Russia

View Trial Details

Completed

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

NCT01846468

Conditions: Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +10 more
Locations: Novartis Investigative Site Orlando, Florida, United States

Novartis Investigative Site Knoxville, Tennessee, United States

View Trial Details

Completed

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

NCT01337752

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations: University Chicago Hospital Dept. of Univ of Chicago (2) Chicago, Illinois, United States

Medical Oncology Associates, PS Spokane, Washington, United States

Novartis Investigative Site Valencia, Spain

Novartis Investigative Site Madrid, Spain

View Trial Details

Completed

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

NCT00770081

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
Locations: University of South Alabama Medical Center Mobile, Alabama, United States

Anasazi Internal Medicine Phoenix, Arizona, United States

Sonoran Health Specialists Scottsdale, Arizona, United States

Mary K. Richards, MD. PA Little Rock, Arkansas, United States

View all 87 locations

View Trial Details